iPSC technology became a promising breakthrough in regenerative medicine since 2006. Because of its high pluripotency, differentiation ability, non-ethical, and -immune problem, iPSC could also be of great use in studying molecular mechanism of many diseases currently. Moreover, iPSC technology has been employed in various diseases for disease modeling and gene therapy. Many toxic compounds which are encountered by humans and newly designed drugs may be evaluated for toxicity and effects by using iPSCs.
The use of iPSCs for disease modeling is based on the fact that these cells are capable of self-renewing and can differentiate into all types of cells of the human body which can be utilized for different disease models to study those diseases.
The use of iPSC-based methodology is their complementarity to drug discovery or prediction of toxicity. Animals or in-vitro animal derived cells are used as testing systems but are limited to replicate the "exact" human physiological conditions and related phenotypic attributions.
In regenerative medicine, the injured tissues are repaired by the generation of those tissues from iPSCs in labs and then transplanting them to the site of injury or degeneration. Important issues associated with gene therapy are availability of tissue or organ and immunorejection.
BioCytoceuticals is an experienced and outstanding provider of iPSC generation service. We are dedicated to providing detailed data and comprehensive service for your scientific research, and we are pleased to use our extensive experience and advanced platform to offer the best service to satisfy each demand from our customers.
If You Have Any Question About Our Service, Please Let Us Know.
Do not hesitate to contact us for this special service. Please let us know what you need and we will accommodate you. We are looking forward to working with you in the future.
Inquiry
